Literature DB >> 24504795

Editorial: Safety of immunosuppressive drugs in pregnant women with systemic inflammatory diseases.

Seoyoung C Kim1, Sonia Hernandez-Diaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24504795      PMCID： PMC3994991          DOI： 10.1002/art.38258

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  17 in total

1.  Pregnancy outcome in women exposed to leflunomide before or during pregnancy.

Authors:  M Cassina; D L Johnson; L K Robinson; S R Braddock; R Xu; J L Jimenez; N Mirrasoul; E Salas; Y J Luo; K L Jones; C D Chambers
Journal:  Arthritis Rheum       Date:  2012-07

Review 2.  Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature.

Authors:  Alla Osadchy; Thirukumaran Ratnapalan; Gideon Koren
Journal:  J Rheumatol       Date:  2011-10-15       Impact factor: 4.666

Review 3.  Drugs in pregnancy. Rheumatological disorders.

Authors:  M Østensen
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2001-12       Impact factor: 5.237

4.  Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

Authors:  M J Casanova; M Chaparro; E Domènech; M Barreiro-de Acosta; F Bermejo; E Iglesias; F Gomollón; L Rodrigo; X Calvet; M Esteve; E García-Planella; S García-López; C Taxonera; M Calvo; M López; D Ginard; M Gómez-García; E Garrido; J L Pérez-Calle; B Beltrán; M Piqueras; C Saro; B Botella; C Dueñas; A Ponferrada; M Mañosa; V García-Sánchez; J Maté; J P Gisbert
Journal:  Am J Gastroenterol       Date:  2013-01-15       Impact factor: 10.864

5.  Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.

Authors:  William O Cooper; T Craig Cheetham; De-Kun Li; C Michael Stein; S Todd Callahan; Thomas M Morgan; Ayumi K Shintani; Ning Chen; Marie R Griffin; Wayne A Ray
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

6.  Birth outcomes in women who have taken leflunomide during pregnancy.

Authors:  Christina D Chambers; Diana L Johnson; Luther K Robinson; Stephen R Braddock; Ronghui Xu; Janina Lopez-Jimenez; Nicole Mirrasoul; Elizabeth Salas; Yunjun J Luo; Shelia Jin; Kenneth Lyons Jones
Journal:  Arthritis Rheum       Date:  2010-05

7.  Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.

Authors:  Suzanne M M Verstappen; Yvonne King; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2011-02-28       Impact factor: 19.103

8.  Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.

Authors:  Jeffry A Katz; Christian Antoni; Gregory F Keenan; Deirdre E Smith; Stephen J Jacobs; Gary R Lichtenstein
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

9.  Disease specific problems related to drug therapy in pregnancy.

Authors:  M Ostensen
Journal:  Lupus       Date:  2004       Impact factor: 2.911

Review 10.  Ciclosporin use during pregnancy.

Authors:  Karolina Paziana; Magaly Del Monaco; Elyce Cardonick; Michael Moritz; Matthew Keller; Bruce Smith; Lisa Coscia; Vincent Armenti
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606
View more
  3 in total

1.  Maternal autoimmune disease and birth defects in the National Birth Defects Prevention Study.

Authors:  Meredith M Howley; Marilyn L Browne; Alissa R Van Zutphen; Sandra D Richardson; Sarah J Blossom; Cheryl S Broussard; Suzan L Carmichael; Charlotte M Druschel
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-11

2.  Therapeutic challenges in the treatment of systemic inflammatory disease in pregnancy.

Authors:  Jared S Fredrickson; Jason R Kolfenbach; Jennifer L Holmes; Jennifer N Cathcart; Anne M Lynch; Alan G Palestine
Journal:  Obstet Med       Date:  2019-01-09

3.  Results of a Survey on Diagnostic Procedures and Treatment Choices for Neuromyelitis Optica Spectrum Disorder in Korea: Beyond the Context of Current Clinical Guidelines.

Authors:  Hye Lim Lee; Su-Hyun Kim; Jin Myoung Seok; Byung Jo Kim; Ho Jin Kim; Byoung Joon Kim
Journal:  J Clin Neurol       Date:  2022-03       Impact factor: 3.077
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.